Related Experiment Videos
Dimethyl sulfoxide therapy in nonmongoloid infantile oligophrenia
Insights
This study investigated the effects of DAT treatment on cognitive function in children with intellectual disabilities. DAT treatment showed significant cognitive improvements compared to conventional treatment, with no observed toxicity.
Area of Science:
- Pediatric Neurology
- Developmental Psychology
Background:
- Intellectual disability, also known as oligophrenia, affects cognitive development.
- Evaluating novel therapeutic interventions is crucial for improving outcomes in affected children.
Purpose of the Study:
- To assess the efficacy of DAT treatment in enhancing cognitive function in children with nonmongoloid intellectual disability.
- To compare the effects of DAT treatment against conventional treatment methods.
Main Methods:
- A cohort of 13 children with intellectual disability received 180 days of DAT treatment.
- Cognitive assessments were performed using the Kuhlmann-standardized Binet-Simon tests and the Terman Merrill test.
- The Bender test was used to assess organic lesions.
- A control group received conventional treatment for comparison.
Main Results:
- The DAT-treated group exhibited a significant mean variation of 0.954, compared to 0.08 in the control group.
- The mean difference between groups was 0.874, with a reliability degree between 0.543 and 1.205.
- The observed cognitive improvements in the DAT-treated group were statistically significant (P=0.01).
- No adverse effects or toxicity were reported in any of the children undergoing DAT treatment.
Conclusions:
- DAT treatment demonstrates a significant positive impact on cognitive function in children with intellectual disability.
- DAT treatment is a safe and effective therapeutic option, showing superiority over conventional treatments.
- Further research into DAT's mechanisms and long-term effects is warranted.
Abstract:
We are herein submitting the results obtained with a group of 13 nonmongoloid, oligophrenic children after 180 days' treatment with DAT, and we have compared the results with those of a control group that received only conventional treatment. The children were examined before and after the treatment by means of the Binet-Simon tests, which have been standardized by Kuhlmann, and the Wise and Terman Merrill test. The control of organic lesion was determined by the Bender test. The variation mean of the control group was 0.08, and that of the DAT-treated group was 0.954; 0.874 was the mean difference, and 0.543 and 1.205 were the degrees of reliability. The difference between the results obtained from the DAT-treated group and the one that received conventional medication was significant (P equal 0.01). None of the 13 cases treated showed any signs of toxicity.